简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

自然另类国际(纳斯达克股票代码:NAII)对比Valens(纳斯达克股票代码:VLNS)金融评论

2022-12-23 14:01

Natural Alternatives International (NASDAQ:NAII – Get Rating) and Valens (NASDAQ:VLNS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Insider and Institutional Ownership

26.9% of Natural Alternatives International shares are held by institutional investors. Comparatively, 3.6% of Valens shares are held by institutional investors. 20.2% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Get Natural Alternatives International alerts:

Earnings & Valuation

This table compares Natural Alternatives International and Valens' gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Natural Alternatives International $170.97 million 0.31 $10.71 million $1.41 6.20
Valens $62.37 million 1.69 -$39.11 million ($2.51) -0.26
Natural Alternatives International has higher revenue and earnings than Valens. Valens is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations and price targets for Natural Alternatives International and Valens, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natural Alternatives International 0 0 0 0 N/A
Valens 1 1 1 0 2.00

Valens has a consensus target price of $2.07, indicating a potential upside of 213.13%. Given Valens' higher possible upside, analysts plainly believe Valens is more favorable than Natural Alternatives International.

Profitability

This table compares Natural Alternatives International and Valens' net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Natural Alternatives International 4.84% 9.78% 6.10%
Valens -274.38% -48.02% -29.74%

Summary

Natural Alternatives International beats Valens on 9 of the 12 factors compared between the two stocks.

About Natural Alternatives International

(Get Rating)

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

About Valens

(Get Rating)

The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada.

Receive News & Ratings for Natural Alternatives International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International and related companies with MarketBeat.com's FREE daily email newsletter.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。